Publication | Closed Access

Oral pirfenidone protects against fibrosis by inhibiting fibroblast proliferation and TGF-β signaling in a murine colitis model

InflammationChronic Inflammatory DiseasesAntifibrotic TherapyFibrosisAnti-inflammatoryOral Pirfenidone ProtectsMedicineTgf-β SignalingImmunologyGastroenterologyChronic InflammationPathologyMurine Colitis ModelPharmacologyInflammatory Disease